Request for proposals: Drug Discovery Research

Brain Canada & Quebec Consortium for Drug Discovery (CQDM) is pleased to share an upcoming funding opportunity for Canadian researchers. CQDM’s Quantum Leap pharma-led funding program for drug discovery research aims to support innovative translational biopharmaceutical research projects that are at advanced stages of development and that have the potential to improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs.

Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

Eligibility

The Quantum Leap pharma-led funding program for drug discovery research is open to all SMEs and public research institutions in Canada.

Because budget structures can vary depending on each project, you must contact CQDM to confirm eligibility before applying 

Funding

CQDM will review applications for its pharma-led funding program for drug discovery research subject to the following:

  • Requested funds must range from $500,000 to $1,200,000. Exceptionally, CQDM may consider applications exceeding the maximum, if appropriate.
  • CQDM pharmaceutical members must have pledged at least one third (1/3) of the funds required to support the project.
  • Applicants are responsible for raising matched funding for the project. When possible, CQDM may offer support to applicants.
  • CQDM may call on a number of national and international partner organizations potentially interested in co-financing certain projects. For example, preliminary discussions with CQDM could help maximize contributions from various partners toward launching a drug discovery research project (see below for details on international collaborations).
  • Applicants with a secured financial commitment from the industry or from a private, semi-private and public organization (either for-profit or non-profit) could be advantaged.
  • The funding may consist in a grant or an investment.
  • A detailed breakdown of requested funding must be provided and will be carefully examined by CQDM.
  • Applicants who wish to apply for Mitacs funding (available to graduate students and postdoctoral fellows involved in a CQDM project) must fill out the appropriate Mitacs section on the CQDM application form.

Duration

Minimum 1 year, maximum 3 years

Application Process

 

Deadline

Call for proposals are open year-round for Quantum Leap projects.
Deadline to participate in the next selection round: May 19th, 2022

 

Website: https://cqdm.org/en/quantum-leap-programme-de-financement-pour-la-recherche-sur-la-decouverte-du-medicament/#

 Questions about this opportunity can be sent to CQDM at appliquez-apply@cqdm.org 

SFU Signature Sheet and Full Application are due to ORS three (3) business days before the application deadline. 

Upcoming Deadlines

External
Internal
May 19, 2023May 19, 2023 *
May 16, 2023 May. 16, 2023 May 16, 2023 16:00:00 May 16, 2023 16:00:00 America/Vancouver Application Deadline: Request for proposals: Drug Discovery Research Brain Canada is partnering with the Quantum Leap pharma-led funding program for drug discovery research on eligible brain related project. Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Please see the funding opportunity link for more information. .
* NOTE: This deadline is an estimate based on previous years, but a confirmed deadline has not yet been published. We will update the deadline when it has been confirmed.
x